Follow the Applied Therapeutics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 4 February 2026 (Disposition). Among the most active insiders: Funtleyder Leslie D.. All data is openly available.
40
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
20 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Applied Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
33Σ signal
Buys n/a€4m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
13,530 shares@ US$5.8323.7% of flowCommon StockSEC:0000950170-24-100222:0
25 of 40 declarations
About Applied Therapeutics, Inc.
Applied Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for chronic diseases. It is listed on NASDAQ under the ticker APLT.